|
|
|
Home > Business > Reuters > Report
Ranbaxy gets USFDA nod for generic Serzone
April 28, 2003 14:29 IST
The United States Food and Drugs Administration has granted Ranbaxy Laboratories a tentative approval to market a generic form of Bristol-Myers' anti-depressant Serzone, US FDA's web site said.
© Copyright 2003 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|
|
|
| Article Tools | | |
| Related Stories | | |
|